Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
13.89
+0.33 (2.43%)
Feb 5, 2025, 9:35 AM EST - Market open
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $491.78 million as of February 5, 2025. Its market cap has decreased by -1.58% in one year.
Market Cap
491.78M
Enterprise Value
92.07M
1-Year Change
-1.58%
Ranking
Category
Stock Price
$13.89
Market Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has increased from $251.01M to $491.78M, an increase of 95.92%. That is a compound annual growth rate of 22.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2025 | 471.95M | -22.90% |
| Dec 31, 2024 | 612.16M | 21.70% |
| Dec 29, 2023 | 503.01M | 18.72% |
| Dec 30, 2022 | 423.70M | -20.71% |
| Dec 31, 2021 | 534.36M | 112.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 743.82B |
| UnitedHealth Group | 501.97B |
| Johnson & Johnson | 369.55B |
| Novo Nordisk | 366.04B |
| AbbVie | 335.67B |
| Merck & Co. | 229.54B |
| Abbott Laboratories | 223.92B |
| Thermo Fisher Scientific | 222.07B |